Equipped with world-leading technology platforms and professional scientific staff, Creative Biolabs has developed an advanced Anti-Gly™ platform for custom anti-glycoprotein antibody development. Several cutting-edge antibody discovery technologies, including phage display technology, hybridoma technology, and antigen-specific B lymphocytes sorting technology, are employed on our Anti-Gly™ platform. With years of experience in the discovery of anti-glycoprotein monoclonal antibodies (mAbs), we can offer high-quality customized services by adjusting protocols to meet even the most specific requirements.
Phage display technology is a powerful tool to discovery mAbs for therapeutic or diagnostic purposes. Creative Biolabs has long-term devoted to the development and application of phage display technology. Our scientists can offer high-quality phage display scFv/Fab/VHH library construction and custom phage display library screening services for the discovery of anti-glycoprotein mAbs. Based on our advanced phage display platform, we have tailored hundreds of scFv/Fab libraries construction and screening services according to our clients’ demands precisely.
Hybridoma technology has greatly increased the specificity of antibodies as well as permitted large-scale production of specific antibodies. To discover anti-glycoprotein mAbs, Creative Biolabs provides a full range of services based on our state-of-the-art hybridoma platform, including gene synthesis, antigen expression to antibody purification and labeling. The quantity of antibodies can be small-scaled for research applications or massive preparation for diagnostic industry. We can offer high-quality mAbs for research, diagnostic, as well as therapeutic antibody developments.
Creative Biolabs has developed antigen-specific B cells sorting platform to retrieve native antibodies with extremely high in vivo specificity and affinity. We employ fluorescent activated cell sorting (FACS), laser-capture microdissection (LCM), microengraving and droplet microfluidics technology to isolate single antigen-specific B cells. Combined with next-generation sequencing (NGS), this cutting-edge platform can be used to isolate mAbs with paired heavy chain and light chain from diverse species, such as humans, rabbits, rats, mice, chickens, camelids, sheep, monkeys, dogs, cows, etc.
Scientists from Creative Biolabs employ proprietary protocols and various strategies to identify anti-glycoprotein mAbs with higher affinity and desired specificity. We can tailor different strategies for the discovery of anti-glycoprotein antibody to meet our clients’ project development goal in a time-saving manner. Through our high-throughput anti-glycoprotein mAbs discovery system, clients could accelerate their research by reducing project costs and timelines. Please feel free to contact us for more information and a detailed quote.